LETTER
Enantioselective Recyclable NADH Mimics
443
(6) Analytical data for (R)-4a: 1H NMR (300 MHz, CDCl3): d =
2.39 (3 H, s), 4.73 (3 H, s), 7.43 (2 H, d, J = 8 Hz), 7.81 (2
H, d, J = 8 Hz), 8.12 (1 H, t, J = 9 Hz), 8.36 (1 H, t, J = 9
Hz), 8.52 (2 H, m), 9.42 (1 H, s), 9.62 (1 H, s). 13C NMR (75
MHz, MeOD): d = 21.8, 47.5, 120.6, 124.3, 127.2, 131.1,
132.4, 132.8, 132.9, 139.2, 141.3, 141.7, 142.8, 144.9,
145.8, 147.8. 19F NMR (282 MHz, CDCl3): d = –80.5.
HRMS (CI): m/z calcd for C17H16NOS: 282.0953. Found:
282.0957.
H
H O
Ph
R
S
CONH2
O
p-Tol
MeOOC
R
N
N
Cl
Me
Me
BNA+
(R)-1a R = H
(R)-1b R = OMe
(b)
CONH2
(a)
O
H
H
R
S
(7) Similar side reactions have already been observed during the
reduction of 3-sulfoxide pyridinium salt under these
conditions. See: Imanishi, T.; Hamano, Y.; Yoshikawa, H.
T.; Iwata, C. J. Chem. Soc., Chem. Commun. 1988, 473.
(8) Analytical data for (R)-1a: 1H NMR (300 MHz, CDCl3): d =
2.76 (3 H, s), 3.45 (1 H, d, J = 19 Hz), 3.59 (3 H, s), 4.13 (1
H, d, J = 19 Hz), 7.05 (1 H, d, J = 8 Hz), 7.27 (2 H, d, J = 8
p-Tol
Ph
H
R
N
OH
N
MeOOC
TfO
Me
Me BNAH
(R)-3a R = H
(R)-3b R = OMe
(R)-1a: yield = 50%; ee = 95% (R)
(R)-1b: yield = 70%; ee = 95% (R)
Hz), 7.47 (1 H, m), 7.65 (3 H, m), 7.87 (2 H, d, J = 8Hz). 13
C
Scheme 5 Reagents and conditions: (a) Mg(ClO4)2, MeCN, r.t., 24
h; (b) MeOTf, CH2Cl2, 20 °C, 2 h; (c) BNAH, CH2Cl2, 20 °C, 2 h.
NMR (75 MHz, CDCl3): d = 21.7, 23.2, 38.9, 109.7, 112.9,
121.7, 123.3, 125.3, 127.7, 130.0, 130.2, 139.2, 139.3,
140.7, 140.8. HRMS (CI): m/z calcd for C17H17NOS:
283.1031. Found: 283.1035.
Acknowledgment
(9) Charpentier, P.; Lobrégat, V.; Levacher, V.; Dupas, G.;
Quéguiner, G.; Bourguignon, J. Tetrahedron Lett. 1998, 39,
4013.
We thank the CNRS, the région Haute-Normandie and the
CRIHAN for financial and technical support.
(10) Analytical data for 2b: 1H NMR (300 MHz, CDCl3): d = 3.98
(3 H, s), 4.00 (3 H, s), 6.92 (1 H, s), 7.34 (1 H, s), 8.10 (1 H,
s), 8.68 (1 H, s). 13C NMR (75 MHz, CDCl3): d = 56.5, 56.6,
104.5, 108.3, 115.6, 125.3, 135.8, 143.9, 149.2, 150.9,
153.0. Anal. Calcd for C11H10BrNO2: C, 49.28; H, 3.76; N,
5.22. Found: C, 49.35; H, 3.82; N, 5.21.
(11) Smith, A. B.; Levenberg, P. A.; Jerris, P. J.; Scarborough, R.
M.; Wovkulich, P. M. J. Am. Chem. Soc. 1981, 103, 1501.
(12) Trofimenko, S. J. Org. Chem. 1963, 28, 3243.
(13) Analytical data for (R)-7b: 1H NMR (300 MHz, CDCl3): d =
2.29 (3 H, s), 3.93 (6 H, s), 7.02 (1 H, s), 7.20 (2 H, d, J = 8
Hz), 7.33 (1 H, s), 7.51 (2 H, d, J = 8 Hz), 8.29 (1 H, s), 8.62
(1 H, s). 13C NMR (75 MHz, CDCl3): d = 21.8, 56.6, 56.7,
105.8, 108.3, 123.6, 125.4, 130.6, 131.4, 137.5, 142.1,
142.5, 144.2, 146.7, 151.1, 154.3. HRMS: m/z calcd for
C18H17NO3S: 327.0929. Found: 327.0933..
References
(1) For leading references of NADH models bearing a sulfoxide
group, see: (a) Li, J.; Liu, Y.-C.; Deng, J.-G. Tetrahedron:
Asymmetry 1999, 10, 4343. (b) Kazuyuki, M.; Nishimoto,
N.; Hidenobu, M.; Asuka, M.; Satoshi, O.; Yasuko, I.;
Toshimasa, I.; Takeshi, I. Chem. Commun. 1996, 2535.
(c) Obika, S.; Nishiyama, T.; Tatematsu, S.; Miyashita, K.;
Iwata, C.; Imanishi, T. Tetrahedron 1997, 53, 593.
(d) Obika, S.; Nishiyama, T.; Tatematsu, S.; Miyashita, K.;
Imanishi, T. Chem. Lett. 1996, 853. (e) Obika, S.;
Nishiyama, T.; Tatematsu, S.; Nishimoto, M.; Miyashita, K.;
Imanishi, T. Heterocycles 1998, 261. (f) Imanishi, T.;
Obika, T.; Nishiyama, T.; Nishimoto, M.; Hamano, Y.;
Miyashita, K.; Iwata, C. Chem. Pharm. Bull. 1996, 44, 267.
(2) For early reports on annelated NADH models, see:
(a) Levacher, V.; Dupas, G.; Quéguiner, G.; Bourguignon, J.
Trends Heterocycl. Chem. 1995, 4, 293. (b) Dupas, G.;
Levacher, V.; Quéguiner, G.; Bourguignon, J. Heterocycles
1994, 39, 405. (c) Vitry, C.; Vasse, J.-L.; Levacher, V.;
Dupas, G.; Quéguiner, G.; Bourguignon, J. Tetrahedron
2001, 57, 3087.
(14) Enantiomeric excesses were determined by HPLC analysis
using a Chiralpak AD column (250 × 4.6 mm; 10 mm).
Chromatographic conditions: eluent: heptane–2-propanol =
85:15; flow rate: 1 mL min–1; pressure: 300 psi; temperature:
19 °C; UV detection: l = 230 nm; tR = 36 min [(S)-
enantiomer] and 40 min [(R)-enantiomer].
(15) Analytical data for (R)-8b: 1H NMR (300 MHz, MeOD): d =
2.39 (3 H, s), 4.06 (3 H, s), 4.20 (3 H, s), 4.62 (3 H, s), 7.42
(2 H, d, J = 8Hz), 7.61 (1 H, s), 7.76 (3 H, m), 9.09 (1 H, s),
9.28 (1 H, s). 13C NMR (75 MHz, MeOD): d = 26.7, 51.7,
62.4, 63.3, 130.7, 113.6, 130.8, 132.3, 136.5, 143.7, 143.9,
144.8, 145.5, 146.6, 149.4, 158.6, 165.2. 19F NMR (282
MHz, CDCl3): d = – 80.25. HRMS: m/z calcd for
(3) Analytical data for (R)-3a: 1H NMR (300 MHz, CDCl3): d =
2.30 (3 H, s), 7.21 (2 H, d, J = 8 Hz), 7.51 (3 H, m), 7.73 (1
H, m), 7.85 (1 H, d, J = 8 Hz), 8.05 (1 H, d, J = 8 Hz), 8.53
(1 H, s), 8.76 (1 H, s). 13C NMR (75 MHz, CDCl3): d = 21.8,
125.6, 127.7, 128.3, 128.8, 129.9, 130.7, 131.7, 133.2,
139.5, 141.7, 142.9, 146.2, 149.1. Anal. Calcd for
C16H13NOS: C, 71.88; H, 4.90; N, 5.24. Found: C, 71.78; H,
4.82; N, 5.10.
(4) Enantiomeric excesses were determined by HPLC analysis
using a Chiracel OJ column (250 × 4.6 mm; 10 mm).
Chromatographic conditions: eluent: heptane–2-propanol =
90:10; flow rate: 1 mL min–1; pressure: 300 psi; temperature:
19 °C; UV detection: l = 230 nm; tR: 22 min [(S)-
enantiomer] and 26 min [(R)-enantiomer].
C19H20NO3S: 342.1164. Found: 342.1165.
(16) Analytical data for (R)-1b: 1H NMR (300 MHz, CDCl3): d =
2.32 (3 H, s), 2.94 (1 H, d, J = 18 Hz), 3.17 (3 H, s), 3.63 (1
H, d, J = 18 Hz), 3.67 (3 H, s), 3.78 (3 H, s), 6.24 (1 H, s),
6.33 (1 H, s), 6.84 (1 H, s), 7.21 (2 H, d, J = 8Hz), 7.43 (2 H,
d, J = 8Hz). 13C NMR (75 MHz, CDCl3): d = 21.8, 21.9,
39.2, 56.5, 56.6, 98.6, 108.5, 113.1, 113.4, 125.4, 130.0,
132.7, 139.2, 140.6, 140.9, 154.2, 148.3. HRMS (CI):
m/z calcd for C19H21NO3S: 343.1242. Found: 343.1249.
(17) Typical Procedure for the Reduction of Methyl
Benzoylformate with Mimics 1a,b:
(5) (a) Dumouchel, S.; Mongin, F.; Trécourt, F.; Quéguiner, G.
Tetrahedron Lett. 2003, 44, 2033. (b) Dumouchel, S.;
Mongin, F.; Trécourt, F.; Quéguiner, G. Tetrahedron 2003,
44, 8629.
In a flask, flushed with argon, were introduced model 1b
(0.283 g, 1 mmol), MeCN (3 mL), methyl benzoylformate
(142 mL, 1 mmol) and Mg(ClO4)2 (224 mg, 1 mmol). The
Synlett 2005, No. 3, 441–444 © Thieme Stuttgart · New York